| 1 day | +1.70% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 74 | - |
Sean Christie
DFI | Director of Finance/CFO | 53 | 2021-07-31 |
Doyle Shane
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ruud Dobber
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/21 | Issuer sale | Chief Operating Officer | 172,582 | 0.0781% | ||
| 7/21/21 | Issuer sale | Director | 28,216 | 0.0128% | ||
| 7/21/21 | Issuer sale | Chief Financial Officer | 120,253 | 0.0544% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.70% | -2.20% | - | - | 40.34B | ||
| -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | ||
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | ||
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | ||
| -0.60% | +2.66% | +38.97% | +64.09% | 379B | ||
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | ||
| +0.76% | +1.60% | +21.99% | +51.38% | 292B | ||
| +0.54% | -0.17% | +1.08% | +25.50% | 262B | ||
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | ||
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | ||
| Average | +0.55% | +3.22% | +35.42% | +69.13% | 443.11B | |
| Weighted average by Cap. | +0.73% | +3.73% | +40.82% | +79.81% |
Employees
3,837
Sector
Pharmaceuticals
















